BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 30703618)

  • 1. Pilot study of DNA methylation-derived neutrophil-to-lymphocyte ratio and survival in pediatric medulloblastoma.
    Arroyo VM; Lupo PJ; Scheurer ME; Rednam SP; Murray J; Okcu MF; Chintagumpala MM; Brown AL
    Cancer Epidemiol; 2019 Apr; 59():71-74. PubMed ID: 30703618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomethylomic approach to explore the blood neutrophil lymphocyte ratio (NLR) in glioma survival.
    Wiencke JK; Koestler DC; Salas LA; Wiemels JL; Roy RP; Hansen HM; Rice T; McCoy LS; Bracci PM; Molinaro AM; Kelsey KT; Wrensch MR; Christensen BC
    Clin Epigenetics; 2017; 9():10. PubMed ID: 28184256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploratory analysis of ERCC2 DNA methylation in survival among pediatric medulloblastoma patients.
    Banfield E; Brown AL; Peckham EC; Rednam SP; Murray J; Okcu MF; Mitchell LE; Chintagumpala MM; Lau CC; Scheurer ME; Lupo PJ
    Cancer Epidemiol; 2016 Oct; 44():161-166. PubMed ID: 27607585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA Methylation-Derived Neutrophil-to-Lymphocyte Ratio: An Epigenetic Tool to Explore Cancer Inflammation and Outcomes.
    Koestler DC; Usset J; Christensen BC; Marsit CJ; Karagas MR; Kelsey KT; Wiencke JK
    Cancer Epidemiol Biomarkers Prev; 2017 Mar; 26(3):328-338. PubMed ID: 27965295
    [No Abstract]   [Full Text] [Related]  

  • 5. Methylation-derived Neutrophil-to-Lymphocyte Ratio and Lung Cancer Risk in Heavy Smokers.
    Grieshober L; Graw S; Barnett MJ; Thornquist MD; Goodman GE; Chen C; Koestler DC; Marsit CJ; Doherty JA
    Cancer Prev Res (Phila); 2018 Nov; 11(11):727-734. PubMed ID: 30254071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subgroup-specific prognostic signaling and metabolic pathways in pediatric medulloblastoma.
    Park AK; Lee JY; Cheong H; Ramaswamy V; Park SH; Kool M; Phi JH; Choi SA; Cavalli F; Taylor MD; Kim SK
    BMC Cancer; 2019 Jun; 19(1):571. PubMed ID: 31185958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of absolute lymphocyte count in children with recurrent medulloblastoma.
    Tomita T; Ammirati M
    Am J Dis Child; 1984 Apr; 138(4):392-4. PubMed ID: 6702793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the Role of DNA Methylation-Derived Neutrophil-to-Lymphocyte Ratio in Rheumatoid Arthritis.
    Ambatipudi S; Sharp GC; Clarke SLN; Plant D; Tobias JH; Evans DM; Barton A; Relton CL
    J Immunol Res; 2018; 2018():2624981. PubMed ID: 30186880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival in pediatric medulloblastoma: a population-based observational study to improve prognostication.
    Weil AG; Wang AC; Westwick HJ; Ibrahim GM; Ariani RT; Crevier L; Perreault S; Davidson T; Tseng CH; Fallah A
    J Neurooncol; 2017 Mar; 132(1):99-107. PubMed ID: 27981412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-operative neutrophil count and neutrophil-lymphocyte count ratio (NLCR) in predicting the histological grade of paediatric brain tumours: a preliminary study.
    Wilson JRF; Saeed F; Tyagi AK; Goodden JR; Sivakumar G; Crimmins D; Elliott M; Picton S; Chumas PD
    Acta Neurochir (Wien); 2018 Apr; 160(4):793-800. PubMed ID: 29188366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays.
    Hovestadt V; Remke M; Kool M; Pietsch T; Northcott PA; Fischer R; Cavalli FM; Ramaswamy V; Zapatka M; Reifenberger G; Rutkowski S; Schick M; Bewerunge-Hudler M; Korshunov A; Lichter P; Taylor MD; Pfister SM; Jones DT
    Acta Neuropathol; 2013 Jun; 125(6):913-6. PubMed ID: 23670100
    [No Abstract]   [Full Text] [Related]  

  • 12. MiR-495 is a Predictive Biomarker that Downregulates GFI1 Expression in Medulloblastoma.
    Wang C; Yun Z; Zhao T; Liu X; Ma X
    Cell Physiol Biochem; 2015; 36(4):1430-9. PubMed ID: 26160036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-diagnosis neutrophil-to-lymphocyte ratio and mortality in individuals who develop lung cancer.
    Grieshober L; Graw S; Barnett MJ; Goodman GE; Chen C; Koestler DC; Marsit CJ; Doherty JA
    Cancer Causes Control; 2021 Nov; 32(11):1227-1236. PubMed ID: 34236573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene-Specific DNA Methylation Profiles in Pediatric Medulloblastomas.
    Kanit N; Uysal Yoca O; Ince D; Olgun N; Ozer E
    Pediatr Dev Pathol; 2022; 25(2):82-90. PubMed ID: 34554028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Method for Rapid Molecular Subgrouping of Medulloblastoma.
    Gómez S; Garrido-Garcia A; Garcia-Gerique L; Lemos I; Suñol M; de Torres C; Kulis M; Pérez-Jaume S; Carcaboso ÁM; Luu B; Kieran MW; Jabado N; Kozlenkov A; Dracheva S; Ramaswamy V; Hovestadt V; Johann P; Jones DTW; Pfister SM; Morales La Madrid A; Cruz O; Taylor MD; Martin-Subero JI; Mora J; Lavarino C
    Clin Cancer Res; 2018 Mar; 24(6):1355-1363. PubMed ID: 29351917
    [No Abstract]   [Full Text] [Related]  

  • 16. Pre-treatment lymphopenia and indication of tumor-induced systemic immunosuppression in medulloblastoma.
    Patel S; Wang S; Snuderl M; Karajannis MA
    J Neurooncol; 2018 Feb; 136(3):541-544. PubMed ID: 29143922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of Ki-67 index in adult medulloblastoma after accounting for molecular subgroup: a retrospective clinical and molecular analysis.
    Zhao F; Zhang J; Li P; Zhou Q; Zhang S; Zhao C; Wang B; Yang Z; Li C; Liu P
    J Neurooncol; 2018 Sep; 139(2):333-340. PubMed ID: 29687281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reliability of molecular tumour markers in children with medulloblastoma--an example from clinical practice].
    Pfister S
    Z Evid Fortbild Qual Gesundhwes; 2011; 105(7):511-3. PubMed ID: 21958611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ALK Expression Is a Novel Marker for the WNT-activated Type of Pediatric Medulloblastoma and an Indicator of Good Prognosis for Patients.
    Łastowska M; Trubicka J; Niemira M; Paczkowska-Abdulsalam M; Karkucińska-Więckowska A; Kaleta M; Drogosiewicz M; Tarasińska M; Perek-Polnik M; Krętowski A; Dembowska-Bagińska B; Grajkowska W; Pronicki M; Matyja E
    Am J Surg Pathol; 2017 Jun; 41(6):781-787. PubMed ID: 28338501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of DNA methyltransferases in primary human medulloblastoma.
    Pócza T; Krenács T; Turányi E; Csáthy J; Jakab Z; Hauser P
    Folia Neuropathol; 2016; 54(2):105-13. PubMed ID: 27543768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.